{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:46:23Z","timestamp":1792691183611,"version":"4.5.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"7","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CN"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Cholecystokinin (CCK), the most abundant brain neuropeptide, is involved in relevant\nbehavioral functions like memory, cognition, and reward through its interactions with the opioid\nand dopaminergic systems in the limbic system. CCK excites neurons by binding two receptors,\nCCK&lt;sub&gt;1&lt;\/sub&gt; and CCK&lt;sub&gt;2&lt;\/sub&gt;, expressed at low and high levels in the brain, respectively. Historically, CCK&lt;sub&gt;2&lt;\/sub&gt;\nreceptors have been related to the induction of panic attacks in humans. Disturbances in brain CCK\nexpression also underlie the physiopathology of schizophrenia, which is attributed to the modulation\nby CCK&lt;sub&gt;1&lt;\/sub&gt; receptors of the dopamine flux in the basal striatum. Despite this evidence, neither\nCCK&lt;sub&gt;2&lt;\/sub&gt; receptor antagonists ameliorate human anxiety nor CCK agonists have consistently shown\nneuroleptic effects in clinical trials. A neglected aspect of the function of brain CCK is its neuromodulatory\nrole in mental disorders. Interestingly, CCK is expressed in pivotal inhibitory interneurons\nthat sculpt cortical dynamics and the flux of nerve impulses across corticolimbic areas and the\nexcitatory projections to mesolimbic pathways. At the basal striatum, CCK modulates the excitability\nof glutamate, the release of inhibitory GABA, and the discharge of dopamine. Here we focus on\nhow CCK may reduce rather than trigger anxiety by regulating its cognitive component. Adequate\nlevels of CCK release in the basal striatum may control the interplay between cognition and reward\ncircuitry, which is critical in schizophrenia. Hence, it is proposed that disturbances in the excitatory\/\ninhibitory interplay modulated by CCK may contribute to the imbalanced interaction between\ncorticolimbic and mesolimbic neural activity found in anxiety and schizophrenia.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570159x18666201113145143","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T12:02:18Z","timestamp":1605268938000},"page":"925-938","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Cholecystokinin-Mediated Neuromodulation of Anxiety and Schizophrenia: A \u201cDimmer-Switch\u201d Hypothesis"],"prefix":"10.2174","volume":"19","author":[{"given":"Santiago J.","family":"Ballaz","sequence":"first","affiliation":[{"name":"School of Biological Sciences & Engineering, Yachay Tech University, Hacienda San Jose s\/n, San Miguel de Urcuqu\u00ed,Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Bourin","sequence":"additional","affiliation":[{"name":"Neurobiology of anxiety and mood disorders, University of Nantes 98, rue Joseph Blanchart, 44100 Nantes,France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570159X18666201113145143","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/187990\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570159X18666201113145143","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T14:17:47Z","timestamp":1655389067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/187990\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570159x18666201113145143","relation":{},"ISSN":["1570-159X"],"issn-type":[{"value":"1570-159X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-08-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}